PAUF/ZG16B Antibody (6E5)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-26244
Recombinant monoclonal antibody expressed in HEK293F cells
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA
Label
Unconjugated
Antibody Source
Recombinant Monoclonal Human IgG1 Clone # 6E5
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for PAUF/ZG16B Antibody (6E5)
Immunogen
Recombinant Human PAUF/ZG16B protein [UniProt Q96DA0]
Clonality
Monoclonal
Host
Human
Isotype
IgG1
Scientific Data Images for PAUF/ZG16B Antibody (6E5)
ELISA: PAUF/ZG16B Antibody (6E5) [NBP3-26244] -
ELISA: PAUF/ZG16B Antibody (6E5) [NBP3-26244] - The Binding Activity of Human PAUF/ZG16B with PAUF/ZG16B Antibody.Activity: Measured by its binding ability in a functional ELISA. Immobilized Human PAUF/ZG16B at 2 ug/mL can bind PAUF/ZG16B Antibody, the EC50 is 24.13-46.04 ng/mL.
Applications for PAUF/ZG16B Antibody (6E5)
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
50% Glycerol, 0.01M PBS, PH 7.4
Preservative
0.03% Proclin 300
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20 to -70C. Avoid freeze-thaw cycles.
Background: PAUF/ZG16B
Long Name
Pancreatic Adenocarcinoma Upregulated Factor
Alternate Names
EECP, HRPE773, JCLN2, LOC124220, PRO1567, ZG16B
Gene Symbol
ZG16B
Additional PAUF/ZG16B Products
Product Specific Notices for PAUF/ZG16B Antibody (6E5)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...